129 related articles for article (PubMed ID: 30570076)
21. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
22. Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Satlin MJ; Vardhana S; Soave R; Shore TB; Mark TM; Jacobs SE; Walsh TJ; Gergis U
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1808-14. PubMed ID: 26150022
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
24. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
25. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.
Poutsiaka DD; Price LL; Ucuzian A; Chan GW; Miller KB; Snydman DR
Bone Marrow Transplant; 2007 Jul; 40(1):63-70. PubMed ID: 17468772
[TBL] [Abstract][Full Text] [Related]
26. The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.
Ford CD; Lopansri BK; Gazdik MA; Snow GL; Webb BJ; Konopa KL; Petersen FB
Transpl Infect Dis; 2015 Oct; 17(5):688-94. PubMed ID: 26256692
[TBL] [Abstract][Full Text] [Related]
27. Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients.
Kimura SI; Gomyo A; Hayakawa J; Akahoshi Y; Harada N; Ugai T; Komiya Y; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kanda J; Kako S; Tanihara A; Kanda Y
J Infect Chemother; 2017 Mar; 23(3):148-153. PubMed ID: 28011352
[TBL] [Abstract][Full Text] [Related]
28. Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation.
Chizuka A; Kami M; Kanda Y; Murashige N; Kishi Y; Hamaki T; Kim SW; Hori A; Kojima R; Mori SI; Tanosaki R; Gomi H; Takaue Y
Bone Marrow Transplant; 2005 Mar; 35(6):577-82. PubMed ID: 15665840
[TBL] [Abstract][Full Text] [Related]
29. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality.
Marena C; Zecca M; Carenini ML; Bruschi A; Bassi ML; Olivieri P; Azzaretti S; Locatelli F
Infect Control Hosp Epidemiol; 2001 Aug; 22(8):510-7. PubMed ID: 11700879
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?
Dubberke ER; Hollands JM; Georgantopoulos P; Augustin K; DiPersio JF; Mundy LM; Khoury HJ
Bone Marrow Transplant; 2006 Dec; 38(12):813-9. PubMed ID: 17057724
[TBL] [Abstract][Full Text] [Related]
31. Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.
Gudiol C; Garcia-Vidal C; Arnan M; Sánchez-Ortega I; Patiño B; Duarte R; Carratalà J
Bone Marrow Transplant; 2014 Jun; 49(6):824-30. PubMed ID: 24662420
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of Clinical Features and Risk Factors for Oral Ulcers and Bloodstream Infection in Patients with Hematopoietic Stem Cell Transplantation].
Wu K; Guan LN; Zhang JY; Zhang R; Bian ZL; Wang C; Wan DM; Cao WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):866-870. PubMed ID: 37356953
[TBL] [Abstract][Full Text] [Related]
33. Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS).
Weisser M; Theilacker C; Tschudin Sutter S; Babikir R; Bertz H; Götting T; Dettenkofer M; Kern WV; Widmer AF;
Clin Microbiol Infect; 2017 Nov; 23(11):854-859. PubMed ID: 28366613
[TBL] [Abstract][Full Text] [Related]
34. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
Choeyprasert W; Hongeng S; Anurathapan U; Pakakasama S
Int J Hematol; 2017 Feb; 105(2):213-220. PubMed ID: 27771837
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Mikulska M; Del Bono V; Prinapori R; Boni L; Raiola AM; Gualandi F; Van Lint MT; Dominietto A; Lamparelli T; Cappellano P; Bacigalupo A; Viscoli C
Transpl Infect Dis; 2010 Dec; 12(6):505-12. PubMed ID: 20636482
[TBL] [Abstract][Full Text] [Related]
36. Bloodstream infection after stem cell transplantation in children with idiopathic aplastic anemia.
Kobayashi R; Yabe H; Kikuchi A; Kudo K; Yoshida N; Watanabe K; Muramatsu H; Takahashi Y; Inoue M; Koh K; Inagaki J; Okamoto Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1145-9. PubMed ID: 24727336
[TBL] [Abstract][Full Text] [Related]
37. Risk factor analysis of bloodstream infection in pediatric patients after hematopoietic stem cell transplantation.
Sarashina T; Yoshida M; Iguchi A; Okubo H; Toriumi N; Suzuki D; Sano H; Kobayashi R
J Pediatr Hematol Oncol; 2013 Jan; 35(1):76-80. PubMed ID: 22995926
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and risk factors for bloodstream infections after allogeneic hematopoietic stem cell transplantion.
Cappellano P; Viscoli C; Bruzzi P; Van Lint MT; Pereira CA; Bacigalupo A
New Microbiol; 2007 Apr; 30(2):89-99. PubMed ID: 17619251
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
40. [Bloodstream infection in patients receiving hematopoietic stem cell transplant. Seven years of experience with adults and children].
Lipari FG; Zárate AH; García JJ; Basquíera AL; Caeiro JP
Rev Chilena Infectol; 2017 Dec; 34(6):535-538. PubMed ID: 29488545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
